awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36892821-AD2D354E-EDF4-470B-B200-0680940A86BC
Q36892821-AD2D354E-EDF4-470B-B200-0680940A86BC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36892821-AD2D354E-EDF4-470B-B200-0680940A86BC
A randomized, phase II, three-arm study of two schedules of ixabepilone or paclitaxel plus bevacizumab as first-line therapy for metastatic breast cancer.
P2860
Q36892821-AD2D354E-EDF4-470B-B200-0680940A86BC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36892821-AD2D354E-EDF4-470B-B200-0680940A86BC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3b675a22222dcaa9e3c6e4887071717b4ae13aac
P2860
Independent review of E2100: a phase III trial of bevacizumab plus paclitaxel versus paclitaxel in women with metastatic breast cancer.